Endoscopic Mucosal Resection and Cellular Matrix
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/20/2019 |
| Start Date: | March 15, 2017 |
| End Date: | April 1, 2020 |
A Randomized Study of Biologic Scaffolds And Esophageal Healing Following Endoscopic Resection
This study is being done to assess the use of scaffold products in promoting constructive
healing as determined by the ability of the resection site to lift during follow-up.
healing as determined by the ability of the resection site to lift during follow-up.
Inclusion Criteria
- 18 and older
- Male or female
- Able to provide consent
- Scheduled for standard of care endoscopy that may require initial EMR evaluation of
esophageal lesions
- Histological evidence of intestinal metaplasia with dysplasia or intramucosal
carcinoma
Exclusion Criteria
- Pregnant women
- Age less than 18
- Prior esophageal EMR or ESD in the same region
- Anyone unable to provide informed consent
- Medical co-morbidities precluding EGD evaluation
- History of chemoradiotherapy to the neck/esophagus
- Unable to stop anticoagulation therapy (non-steroid anti-inflammatory medications are
permissible)
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
